IMM-6-415 is an oral, twice-daily Deep Cyclic Inhibitor currently in a Phase 1/2a trial in patients with advanced solid tumors harboring RAS or RAF mutations. The company’s development pipeline ...

Besides IMM-1-104, Immuneering has another pipeline candidate, IMM-6-415, which is being evaluated in a separate phase I/IIa study in patients with advanced solid tumors harboring RAS or RAF ...

Incredible photos show the flames that burned for more than three hours in the $1.5 million Lake Norman home, located on a ...

IMM-6-415 is an oral, twice-daily Deep Cyclic Inhibitor currently in a phase 1/2a trial in patients with advanced solid tumors harboring RAS or RAF mutations. The company’s development pipeline also ...

Shares of Immuneering Co. (NASDAQ:IMRX – Get Free Report) have been given an average rating of “Moderate Buy” by the seven ...

When the name Val Imm is uttered in this town, it’s usually in reference to the man who spent 30 years in the state Senate representing his fellow Mankatoans. Or perhaps to the road that snakes ...

Spain will deploy an aid package worth 10.6 billion euros ($11.5 billion) to help regions recover from its deadliest floods in a generation, Prime Minister Pedro Sanchez said on Tuesday.

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

IMM-6-415 is an oral, twice-daily Deep Cyclic Inhibitor currently in a Phase 1/2a trial in patients with advanced solid tumors harboring RAS or RAF mutations. The company’s development ...